Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vaccinex Inc (NQ: VCNX ) 3.220 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 6,605 Open 3.220 Bid (Size) 3.150 (1) Ask (Size) 3.500 (19) Prev. Close 3.220 Today's Range 3.220 - 3.220 52wk Range 1.390 - 13.16 Shares Outstanding 65,941,086 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC November 07, 2024 Partnerships will employ Vaccinex’s ActivMAb® platform for viral display of complex antigens to enable antibody discovery From Vaccinex, Inc. Via GlobeNewswire Vaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual Meeting November 05, 2024 Pepinemab appears to enhance clinical activity of immune checkpoint inhibitors via induction of mature tertiary lymphoid structures in tumors of patients with HPV-negative head and neck cancer. From Vaccinex, Inc. Via GlobeNewswire Performance YTD -69.49% -69.49% 1 Month +48.39% +48.39% 3 Month -32.78% -32.78% 6 Month -42.10% -42.10% 1 Year -74.44% -74.44% More News Read More VCNX Stock Earnings: Vaccinex Reported Results for Q2 2024 August 14, 2024 Via InvestorPlace VCNX Stock Earnings: Vaccinex Reported Results for Q1 2024 May 16, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Friday's After-Market Session November 01, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session October 31, 2024 Via Benzinga Vaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference in Madrid, Spain October 31, 2024 From Vaccinex, Inc. Via GlobeNewswire Vaccinex to Report Promising New Efficacy Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab at Clinical Trials on Alzheimer’s Disease (CTAD) Conference on October 31, 2024 October 24, 2024 From Vaccinex, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's After-Market Session October 15, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session October 10, 2024 Via Benzinga What's Going On With Vaccinex Stock Wednesday? September 18, 2024 Via Benzinga Vaccinex Announces Exercise of Warrants for $6.2 Million in Gross Proceeds September 18, 2024 From Vaccinex, Inc. Via GlobeNewswire Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer’s Disease and Plans to Pursue a Development Partnership August 14, 2024 From Vaccinex, Inc. Via GlobeNewswire Around $3M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying August 02, 2024 Via Benzinga Why DoorDash Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket August 02, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday August 02, 2024 Via InvestorPlace Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease July 31, 2024 From Vaccinex, Inc. Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday July 29, 2024 Via InvestorPlace Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease at the Alzheimer’s Association International Conference, Philadelphia, July 31, 2024 July 17, 2024 From Vaccinex, Inc. Via GlobeNewswire Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease June 06, 2024 From Vaccinex, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session May 31, 2024 Via Benzinga Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 31, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session May 27, 2024 Via Benzinga Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update May 15, 2024 From Vaccinex, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session May 10, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
